Invizyne technologies expands leadership team ahead of proposed offering and listing on nasdaq

Michael heltzen appointed as ceo bringing 20 years of global commercial leadership experience and a track record of successful launches and exits additional industry veterans join in key roles including business development, finance, and communications monrovia, calif., may 07, 2024 (globe newswire) -- invizyne technologies, inc. , a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and chemicals for everyday life, today announced the appointment of michael heltzen as ceo, and the recent hirings of additional seasoned industry executives for its leadership team.
MDBH Ratings Summary
MDBH Quant Ranking